Epic Therapeutics Acquired by Baxter International

• TM Capital advised Epic Therapeutics, Inc. in its acquisition by Baxter Healthcare Corporation (NYSE:BAX) subsequent to a collaboration agreement and investment by Baxter, which was also negotiated by TM Capital
• Epic Therapeutics is a privately-held drug delivery company which has developed PROMAXX, a proprietary, water-based delivery technology that can be used in a variety of pharmaceutical agents and routes of administration
• Baxter is a global health care company that provides critical therapies for people with life-threatening conditions

See Press Release